The FDA Just Approved “Viagra for Women”

Flibanserin, a drug to treat low sexual desire in women. Allen Breed/AP

Facts matter: Sign up for the free Mother Jones Daily newsletter. Support our nonprofit reporting. Subscribe to our print magazine.


More than 17 years after it ushered in Viagra, the Federal Drug Administration approved the first women’s sex-drive drug, flibanserin, earlier today.  Sprout Pharmaceuticals will manufacture the drug, which they’ve named Addyi, and sell it to women with low libido, or hypoactive sexual desire disorder (HSDD).

While the pill has garnered much attention under monikers like “pink Viagra” or “Viagra for women,” its purpose and mechanism have little in common with the famous blue pill for men. The drug will not physically bring blood to parts of the body to assist arousal, but instead will alter chemicals in the brain to increase sexual desire.

Is this a victory for women after decades of being ignored by biased pharmaceutical researchers?

Well, not necessarily. As we reported in June:

Women who took the drug in trials reported no more than one additional “sexually satisfying event” per month than women who received a placebo.

Not a great track record. Many health experts and academics doubt the existence of HSDD and believe Big Pharma is fabricating a disorder and exploiting gender imbalances to create a new market. Private investors staked some $50 million on flibanserin’s approval, according to Forbes.

The FDA’s decision came after two prior rejections of the drug because of side effects like dry mouth, fatigue, nausea, and fainting. On the bright side, consumers of Addyi ready to jump into bed will be relieved to hear that the side effects have apparently been diminished.

THE TRUTH...

is the first thing despots go after. An unwavering commitment to it is probably what draws you to Mother Jones' journalism. And as we're seeing in the US and the world around, authoritarians seek to poison the discourse and the way we relate to each other because they can't stand people coming together around a shared sense of the truth—it's a huge threat to them.

Which is also a pretty great way to describe Mother Jones' mission: People coming together around the truth to hold power accountable.

And right now, we need to raise about $400,000 from our online readers over the next two months to hit our annual goal and make good on that mission. Read more about the information war we find ourselves in and how people-powered, independent reporting can and must rise to the challenge—and please support our team's truth-telling journalism with a donation if you can right now.

payment methods

THE TRUTH...

is the first thing despots go after. An unwavering commitment to it is probably what draws you to Mother Jones' journalism. And as we're seeing in the US and the world around, authoritarians seek to poison the discourse and the way we relate to each other because they can't stand people coming together around a shared sense of the truth—it's a huge threat to them.

Which is also a pretty great way to describe Mother Jones' mission: People coming together around the truth to hold power accountable.

And right now, we need to raise about $400,000 from our online readers over the next two months to hit our annual goal and make good on that mission. Read more about the information war we find ourselves in and how people-powered, independent reporting can and must rise to the challenge—and please support our team's truth-telling journalism with a donation if you can right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate